Ohcanbohtosat - Cancel, Mathilde
- Čájehuvvo 1 - 4 / 4
-
1
The Calcium-Sensing Receptor is A Marker and Potential Driver of Neuroendocrine Differentiation in Prostate Cancer Dahkki Bery, Fanny, Cancel, Mathilde, Chantôme, Aurélie, Guibon, Roseline, Bruyère, Franck, Rozet, François, Mahéo, Karine, Fromont, Gaëlle
Almmustuhtton 2020Teaksta -
2
Zeb1 and SK3 Channel Are Up-Regulated in Castration-Resistant Prostate Cancer and Promote Neuroendocrine Differentiation Dahkki Bery, Fanny, Cancel, Mathilde, Guéguinou, Maxime, Potier-Cartereau, Marie, Vandier, Christophe, Chantôme, Aurélie, Guibon, Roseline, Bruyère, Franck, Fromont, Gaëlle, Mahéo, Karine
Almmustuhtton 2021Teaksta -
3
Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer Dahkki Pobel, Cedric, Auclin, Edouard, Teyssonneau, Diego, Laguerre, Brigitte, Cancel, Mathilde, Boughalem, Elouen, Noel, Johanna, Brachet, Pierre Emmanuel, Maillet, Denis, Barthelemy, Philippe, Helissey, Carole, Thibault, Constance, Oudard, Stéphane
Almmustuhtton 2021Teaksta -
4
Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma: The SAVOIR Phase 3 Randomized Clinical Trial Dahkki Choueiri, Toni K., Heng, Daniel Y. C., Lee, Jae Lyun, Cancel, Mathilde, Verheijen, Remy B., Mellemgaard, Anders, Ottesen, Lone H., Frigault, Melanie M., L’Hernault, Anne, Szijgyarto, Zsolt, Signoretti, Sabina, Albiges, Laurence
Almmustuhtton 2020Teaksta